Загрузка...
Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
Objectives: The aim of our study was to evaluate the outcome of alternative sequences of sunitinib followed by sorafenib versus sorafenib followed by sunitinib therapies in patients with metastatic renal cell carcinoma (mRCC). Materials and Methods: This single-center study analyzed patients with mR...
Сохранить в:
| Опубликовано в: : | Cureus |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cureus
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516620/ https://ncbi.nlm.nih.gov/pubmed/31131167 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4244 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|